skip to main content

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

News

Ruth Ley receives Advanced Grant from the European Research Council
11.04.2024 Ruth Ley receives Advanced Grant from the European Research Council Press Release
Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen"
01.04.2024 Podcast "Bakterien kontrollieren: Gute Bakterien nutzen, böse bekämpfen" In the Media

Exzellent erklärt

Decoding new gene functions in the human gut microbiome
26.03.2024 Decoding new gene functions in the human gut microbiome CMFI News

Events

Drug screening and drug target identification using yeast
18.04.2024 Drug screening and drug target identification using yeast 12:30 pm 2:00 pm Joint Microbiological Colloquium Yoko Yashiroda More
Drug-microbe interactions - learning mechanisms from large data approaches
25.04.2024 Drug-microbe interactions - learning mechanisms from large data approaches 12:30 pm 2:00 pm Joint Microbiological Colloquium Ana Brochado More
Research with vulnerable people
14.05.2024 – 15.05.2024 Research with vulnerable people Symposium Urban Wiesing More

About the CMFI

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. 

 

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

The Cluster of Excellence CMFI brings together researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.

The CMFI is one of more than 50 Clusters of Excellence funded by German federal and state governments as part of the Excellence Initiative to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.

More about the Research